TRIM47 could be regarded as a biomarker to guide early diagnosis and therapy in colorectal cancer patients, and pharmaceutical intervention to TRIM47 expression may provide a promising strategy to improve the outcome of CRC. Here, TRIM47 is linked to colorectal cancer.